Outcome After Conservative Surgery and Breast Irradiation in 5,717 Patients With Breast Cancer: Implications for Supraclavicular Nodal Irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 978-983

  Livi, Lorenzo ^a   Scotti, Vieri ^a   Saieva, Calogero ^b   Meattini, Icro ^a   Detti, Beatrice ^a   Simontacchi, Gabriele ^a   Cardillo, Carla Deluca ^a   Paiar, Fabiola ^a   Mangoni, Monica ^a   Marrazzo, Livia ^a   Agresti, Benedetta ^a   Cataliotti, Luigi ^a   Bianchi, Simonetta ^a   Biti, Giampaolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Scientific Institute of Tuscany   (Italy)

Author keywords

Breast cancer; Breast conserving therapy; Radiation; Supraclavicular nodal failure

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; AXILLARY LYMPH NODES; AXILLARY NODES; BREAST CANCER; BREAST CONSERVING SURGERY; BREAST IRRADIATION; BREAST-CONSERVING THERAPY; CONSERVATIVE SURGERY; DISTANT METASTASIS; LOCAL RECURRENCE; PATIENT POPULATION; PREDICTIVE FACTORS; PROGNOSTIC FACTORS; TAMOXIFEN; UNIVERSITY OF FLORENCE;

CHEMOTHERAPY; IRRADIATION; PATHOLOGY; SURGERY;

RADIOTHERAPY;

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77449126625     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.001     Document Type: Article

References (41)

1. Galimberti V. International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol 24 (2006) 210-211
2. Gentilini O., Botteri E., Rotmensz N., et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat 113 (2009) 577-583
3. Intra M., Rotmensz N., Mattar D., et al. Unnecessary axillary node dissections in the sentinel lymph node era. Eur J Cancer 43 (2007) 2664-2668
4. Belkacémi Y., Chauvet M.P., Giard S., et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: Early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol 90 (2009) 23-29
5. Ivaldi G.B., Leonardi M.C., Orecchia R., et al. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys 72 (2008) 485-493
6. Livi L., Paiar F., Buonamici F.B., et al. Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: A preliminary study. Tumori 91 (2005) 227-232
7. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
8. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
9. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group (DBCG) 82c randomised trial. Lancet 353 (1999) 1641-1648
10. Pierce L.J., and Glatstein E. Postmastectomy radiotherapy in the management of operable breast cancer. Cancer 74 (1994) 477-485
11. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
12. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355 (2000) 1757-1770
13. Eifel P., Axelson J.A., Costa J., et al. National Institutes of Health Consensus Development Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93 (2001) 978-979
14. Whelan T.J., Julian J., Wright J., et al. Does locoregional radiotherapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
15. Kingsmore D.B., Hole D.J., Gillis C.R., et al. Axillary recurrence in breast cancer. Eur J Oncol 31 (2005) 226-231
16. Axelsson C.K., Mouridsen H.T., and Zedeler K. Axillary dissection for level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 28 (1992) 1415-1418
17. Strom E.A., Woodward W.A., Katz A., et al. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1508-1513
18. International Commission of Radiation Units and Measurements. Dose specification for reporting external beam therapy with photons and electrons. Report 50 (1992), ICRU, Bethesda, MD
19. Hellman S. Stopping metastases at their source. N Engl J Med 337 (1997) 996-997
20. Koscielny S., and Tubiana M. The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys 43 (1999) 11-24
21. Arriagada R., and Lê M.G. Adjuvant radiotherapy in breast cancer. The treatment of lymph node areas. Acta Oncol 39 (2000) 295-305
22. Mamounas E.P. NSABP breast cancer clinical trials: Recent results and future directions. Clin Med Res 1 (2003) 309-326
23. Wang C.W., Kuo W.H., Chang K.J., et al. Should adjuvant radiotherapy to the supraclavicular fossa be routinely give in patients with breast conservative treatment?. J Surg Oncol 96 (2007) 144-150
24. Galimberti V., Leonardi M.C., Rotmensz N., et al. Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology. Tumori 94 (2008) 52-58
25. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
26. Pergolizzi S., Adamo V., Russi E., et al. Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases. Int J Radiat Oncol Biol Phys 65 (2006) 25-32
27. Truong P.T., Jones S.O., Kader H.A., et al. Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risk compared with node-negative patients after breast conserving surgery and whole breast radiotherapy. Int J Radiat Oncol Biol Phys 73 (2009) 357-364
28. Stranzl H., Ofner P., and Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumour extension on locoregional and distant control?. Strahlenther Onkol 182 (2006) 583-588
29. Truong P.T., Olivotto I.A., Whelan T.J., et al. Clinical practice guidelines for the care and treatment of breast cancer: 16. Loco-regional postmastectomy radiotherapy. CMAJ 170 (2004) 1263-1273
30. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Loco-regional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
31. Danish Breast Cancer Cooperative Group, Nielsen H.M., Overgaard M., et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82b and c randomized studies. J Clin Oncol 24 (2006) 2268-2275
32. Whelan T., and Levine M. More evidence that loco-regional radiation therapy improves survival: What should we do?. J Natl Cancer Inst 97 (2005) 82-84
33. Vicini F.A., Horwitz E.M., Lacerna M.D., et al. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 39 (1997) 1069-1076
34. Grills I.S., Kestin L.L., Goldstein N., et al. Risk factors for regional nodal failure after breast-conserving therapy: Regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 56 (2003) 658-670
35. Ampil F.L., Caldito G., Li B.D., et al. Supraclavicular nodal relapse of breast cancer: Prevalence, palliation, and prognosis. Eur J Gynaecol Oncol 24 (2003) 233-235
36. Pejavar S., Wilson L.D., and Haffty B.G. Regional node recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT). Int J Radiat Oncol Biol Phys 66 (2006) 1320-1327
37. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet 365 (2005) 1687-1717
38. Coen J.J., Taghian A.G., Kachnic L.A., et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55 (2003) 1209-1215
39. Pierce S.M., Recht A., Lingos T.I., et al. Long term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23 (1992) 915-923
40. Chua B., Ung O., and Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J 8 (2002) 15-22
41. Acharya C.R., Hsu D.S., Anders C.K., et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA 299 (2008) 1574-1587